[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556289":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":26,"centralContacts":30,"locations":36,"responsibleParty":121,"collaborators":123,"id":127,"slug":21,"hasResults":128,"nctId":129,"briefTitle":130,"officialTitle":131,"acronym":21,"eligibilityCriteria":132,"healthyVolunteers":128,"sex":133,"minAge":134,"maxAge":21,"enrollmentInfo":135,"targetDuration":21,"studyType":138,"phases":139,"briefSummary":141,"conditions":142,"keywords":145,"overallStatus":77,"whyStopped":21,"lastUpdateSubmitDate":148,"lastUpdatePostDateStruct":149,"startDateStruct":152,"completionDateStruct":154,"leadSponsor":156,"locationsCount":157},{"fullName":5,"class":6},"University Hospitals Cleveland Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Left Atrial Appendage Occlusion (LAAC) with Watchman FLX.","EXPERIMENTAL","Patients who are status post LAAC using the Watchman FLX.",[13,14],"Procedure: Transesophageal echocardiography (TEE)","Procedure: Cardiac CTA",[16,22],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"PROCEDURE","Transesophageal echocardiography (TEE)","TEE will be performed using a 3D probe. TEE images will be acquired at the standard 0, 45, 90, and 135 degree views along with a 3D acquisition encompassing the entire LAA, device, left pulmonary vein and lateral mitral annular landmarks.",[9],null,{"type":17,"name":23,"description":24,"armGroupLabels":25,"otherNames":21},"Cardiac CTA","Cardiac CTA will be performed with ECG gating using systems with ≥ 64 detector rows and with temporal resolution that is at least 175 msec (rotation speed ≤ 350 msec for single source systems). Cardiac CTA images will be acquired for the entire cardiac cycle without ECG phase specific pulsing and with contrast appropriately timed for peak left atrial\u002Farterial phase contrast enhancement. In addition, a targeted end systolic only delayed phase image set (45 seconds after the arterial phase scan and limited to the left atrium and appendage device) will be acquired.",[9],[27],{"name":28,"affiliation":5,"role":29},"Steven Filby, MD","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":21,"email":35},"Amy McKnight, RN, BSN, BCCV","CONTACT","216-983-4896","Amy.McKnight@UHhospitals.org",[37,58,75,93,105],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Cedars Sinai","NOT_YET_RECRUITING","Los Angeles","California","90048","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-118.24368,34.05223,{"lat":49,"lon":48},[52,56],{"name":53,"role":33,"phone":54,"phoneExt":21,"email":55},"Rhona Littman","310-423-4387","*Littmanr@cshs.org",{"name":57,"role":29,"phone":21,"phoneExt":21,"email":21},"John Friedman, MD",{"facility":59,"status":39,"city":60,"state":61,"zip":62,"country":43,"countryCode":44,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"St. Francis Hospital and Catholic Health","Roslyn","New York","11576",{"type":46,"coordinates":64},[65,66],-73.65096,40.79982,{"lat":66,"lon":65},[69,73],{"name":70,"role":33,"phone":71,"phoneExt":21,"email":72},"Elizabeth Haag, RN, MPA","516-622-4512","Elizabeth.Hagg@chsli.org",{"name":74,"role":29,"phone":21,"phoneExt":21,"email":21},"Omar Khlaique, MD",{"facility":76,"status":77,"city":78,"state":79,"zip":80,"country":43,"countryCode":44,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Sanger Heart & Vascular Institute- Atrium Health","RECRUITING","Charlotte","North Carolina","28277",{"type":46,"coordinates":82},[83,84],-80.84313,35.22709,{"lat":84,"lon":83},[87,91],{"name":88,"role":33,"phone":89,"phoneExt":21,"email":90},"Dana Amaro, MSN, RN","704-355-4692","Dana.Amaro@atriumhealth.org",{"name":92,"role":29,"phone":21,"phoneExt":21,"email":21},"Markus Scherer, MD",{"facility":5,"status":39,"city":94,"state":95,"zip":96,"country":43,"countryCode":44,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"Cleveland","Ohio","44106",{"type":46,"coordinates":98},[99,100],-81.69541,41.4995,{"lat":100,"lon":99},[103,104],{"name":32,"role":33,"phone":34,"phoneExt":21,"email":35},{"name":28,"role":29,"phone":21,"phoneExt":21,"email":21},{"facility":106,"status":39,"city":107,"state":95,"zip":108,"country":43,"countryCode":44,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"Ohio State University Medical Center","Columbus","43210",{"type":46,"coordinates":110},[111,112],-82.99879,39.96118,{"lat":112,"lon":111},[115,119],{"name":116,"role":33,"phone":117,"phoneExt":21,"email":118},"Adrianne Miller, MS, CCRP","614-688-8252","Adrianne.Miller3@osumc.edu",{"name":120,"role":29,"phone":21,"phoneExt":21,"email":21},"Mahmoud Houmssee, MD",{"type":29,"investigatorFullName":28,"investigatorTitle":122,"investigatorAffiliation":5,"oldNameTitle":21,"oldOrganization":21},"Physician, Interventional Cardiology",[124],{"name":125,"class":126},"Boston Scientific Corporation","INDUSTRY","100556289",false,"NCT06523166","Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics","Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics: A Multicenter Study","Inclusion Criteria:\n\n* Subjects \\>18 years old planned to undergo LAAC\n* eGFR ≥ 30 mL\u002Fmin per 1.73 m2\n\nExclusion Criteria:\n\n* Subjects below the age of 18\n* non-English speaking subjects\n* eGFR \\\u003C 30 mL\u002Fmin per 1.73 m2\n* Subjects with history of contrast allergy\n* Pregnant women","ALL","18 Years",{"count":136,"type":137},320,"ESTIMATED","INTERVENTIONAL",[140],"NA","The current standard of care for patients who underwent left atrial appendage closure (LAAC) is to have follow-up transesophageal echocardiogram (TEE) for device surveillance. TEE is an ultrasound of the heart done by placing a probe in the esophagus under conscious sedation. It does not use contrast but can be cumbersome to patients as it involves placing a probe in the esophagus. Cardiac computerized tomography angiography (cardiac CTA) is a non-invasive imaging modality that involves the use of certain types of x-rays, contrast (dye) and special computers to generate accurate images of the heart. Participants in this study will undergo both TEE and CTA on the same day 90 days after their LAAC procedure.\n\nParticipants will be in this research study for a period of 1 year, starting from the day of their scheduled LAAC procedure. Participants will undergo a TEE at 90 days after their procedure which is the standard of care imaging study after LAAC. As part of this study, participants will also undergo a cardiac CTA at 90 days as well. Participants will have a routine follow-up visit following device placement as per standard of care as well as a brief phone \"check in\" at 1 year.",[143,144],"Device Related Thrombosis","Peri-device Leak",[146,147,18,23],"Watchman FLX","Left atrial appendage (LAA)","2026-04-01",{"date":150,"type":151},"2026-04-07","ACTUAL",{"date":153,"type":151},"2026-03-27",{"date":155,"type":137},"2026-08-31",{"name":5,"class":6},5]